Article Text

Download PDFPDF

Takayasu arteritis: a review
Free
  1. S L Johnston,
  2. R J Lock,
  3. M M Gompels
  1. Department of Immunology and Immunogenetics, Southmead Hospital, Westbury on Trym, Bristol BS10 5NB, UK
  1. Correspondence to:
 Dr S L Johnston, Department of Immunology and Immunogenetics, Southmead Hospital, Westbury on Trym, Bristol BS10 5NB, UK;
 sljoh{at}hotmail.com

Abstract

Takayasu arteritis is a well known yet rare form of large vessel vasculitis. This review details the history, clinical features, differential diagnoses, classification, and immunology of the disorder. Suppression of inflammation and preservation of vascular competence are the aims of treatment. As with any rare disease, randomised controlled treatment trials are either lacking or based on small patient numbers, making management decisions difficult. Current evidence based treatments are presented and discussed.

  • arteritis
  • pathogensis
  • Takayasu
  • treatment
  • ACR, American College of Rheumatology
  • CRP, C reactive protein
  • ESR, erythrocyte sedimentation rate
  • HLA, human leucocyte antigen
  • IL, interleukin
  • MRA, magnetic resonance angiography

Statistics from Altmetric.com

Footnotes

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.